Table 3.
Real-world patients with diabetes (all) |
Real-world patients with diabetes and without cardiovascular disease |
|||
---|---|---|---|---|
Total number of patients | N=45 463 |
N=33 219 |
||
Simvastatin (C10AA01) equivalent dose* | At initiation | After follow-up | At initiation | After follow-up |
5 mg | 142 (<1) | 185 (<1) | 105 (<1) | 142 (<1) |
10 mg | 12 180 (27) | 11 079 (24) | 9645 (29) | 8671 (26) |
20 mg | 23 671 (52) | 23 065 (51) | 17 803 (54) | 17 364 (52) |
40 mg | 7178 (16) | 8508 (19) | 4097 (12) | 5261 (16) |
80 mg | 2017 (4) | 2197 (5) | 1409 (4) | 1518 (5) |
>80 mg | 225 (<1) | 368 (<1) | 120 (<1) | 216 (<1) |
*For equivalence, atorvastatin 10 mg=fluvastatin 80 mg=lovastatin 40 mg=pravastatin 40 mg=simvastatin 20 mg ≤rosuvastatin 5 mg.29